293 related articles for article (PubMed ID: 27349807)
41. Hot Melt Extrudates Formulated Using Design Space: One Simple Process for Both Palatability and Dissolution Rate Improvement.
Malaquias LFB; Schulte HL; Chaker JA; Karan K; Durig T; Marreto RN; Gratieri T; Gelfuso GM; Cunha-Filho M
J Pharm Sci; 2018 Jan; 107(1):286-296. PubMed ID: 28847477
[TBL] [Abstract][Full Text] [Related]
42. Effect of melt extrudability and melt binding efficiency of polyvinyl caprolactam polyvinyl acetate polyethylene glycol graft copolymer (Soluplus®) on release pattern of hydrophilic and high dose drugs.
Tousif Ayyub K; Moravkar K; Maniruzzaman M; Amin P
Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():563-574. PubMed ID: 30889730
[TBL] [Abstract][Full Text] [Related]
43. Synergistic Effect of Polyvinyl Alcohol and Copovidone in Itraconazole Amorphous Solid Dispersions.
Wlodarski K; Zhang F; Liu T; Sawicki W; Kipping T
Pharm Res; 2018 Jan; 35(1):16. PubMed ID: 29305665
[TBL] [Abstract][Full Text] [Related]
44. Adding a New Dimension to the Amorphous Solid Dispersion Phase Diagram: Studying Dissolution Kinetics of Crystalline Drugs in a Polymer Matrix Using Temperature Dependent XRPD and DSC.
Seiler VK; Theil F; Nagel N; van Lishaut H
J Pharm Sci; 2022 Sep; 111(9):2496-2504. PubMed ID: 35405124
[TBL] [Abstract][Full Text] [Related]
45. How changes in molecular weight and PDI of a polymer in amorphous solid dispersions impact dissolution performance.
Auch C; Harms M; Mäder K
Int J Pharm; 2019 Feb; 556():372-382. PubMed ID: 30553957
[TBL] [Abstract][Full Text] [Related]
46. An innovative carrier for the formulation of amorphous solid dispersion by hot-melt extrusion with no further downstream processes: a case study with indomethacin.
Lacerda SP; Del Confetto S; Haurie L; Bernard M; Faget S; Ré MI
Pharm Dev Technol; 2024 Feb; 29(2):131-142. PubMed ID: 38235570
[TBL] [Abstract][Full Text] [Related]
47. Dissolution enhancement of poorly water-soluble APIs processed by hot-melt extrusion using hydrophilic polymers.
Maniruzzaman M; Rana MM; Boateng JS; Mitchell JC; Douroumis D
Drug Dev Ind Pharm; 2013 Feb; 39(2):218-27. PubMed ID: 22452601
[TBL] [Abstract][Full Text] [Related]
48. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: selection of polymer-surfactant combinations using solubility parameters and testing the processability.
Ghebremeskel AN; Vemavarapu C; Lodaya M
Int J Pharm; 2007 Jan; 328(2):119-29. PubMed ID: 16968659
[TBL] [Abstract][Full Text] [Related]
49. Raman spectroscopy for the in-line polymer-drug quantification and solid state characterization during a pharmaceutical hot-melt extrusion process.
Saerens L; Dierickx L; Lenain B; Vervaet C; Remon JP; De Beer T
Eur J Pharm Biopharm; 2011 Jan; 77(1):158-63. PubMed ID: 20933084
[TBL] [Abstract][Full Text] [Related]
50. Solubility parameter-based screening methods for early-stage formulation development of itraconazole amorphous solid dispersions.
Piccinni P; Tian Y; McNaughton A; Fraser J; Brown S; Jones DS; Li S; Andrews GP
J Pharm Pharmacol; 2016 May; 68(5):705-20. PubMed ID: 26864155
[TBL] [Abstract][Full Text] [Related]
51. Development of Tablet Formulation of Amorphous Solid Dispersions Prepared by Hot Melt Extrusion Using Quality by Design Approach.
Agrawal A; Dudhedia M; Deng W; Shepard K; Zhong L; Povilaitis E; Zimny E
AAPS PharmSciTech; 2016 Feb; 17(1):214-32. PubMed ID: 26757898
[TBL] [Abstract][Full Text] [Related]
52. Solid state solubility of miconazole in poly[(ethylene glycol)-g-vinyl alcohol] using hot-melt extrusion.
Litvinov VM; Guns S; Adriaensens P; Scholtens BJ; Quaedflieg MP; Carleer R; Van den Mooter G
Mol Pharm; 2012 Oct; 9(10):2924-32. PubMed ID: 22905779
[TBL] [Abstract][Full Text] [Related]
53. Polymeric formulations for drug release prepared by hot melt extrusion: application and characterization.
Stanković M; Frijlink HW; Hinrichs WL
Drug Discov Today; 2015 Jul; 20(7):812-23. PubMed ID: 25660507
[TBL] [Abstract][Full Text] [Related]
54. Effect of carbamazepine on viscoelastic properties and hot melt extrudability of Soluplus ®.
Gupta SS; Parikh T; Meena AK; Mahajan N; Vitez I; Serajuddin ATM
Int J Pharm; 2015 Jan; 478(1):232-239. PubMed ID: 25448585
[TBL] [Abstract][Full Text] [Related]
55. Spray-dried solid dispersions of nifedipine and vinylcaprolactam/vinylacetate/PEG₆₀₀₀ for compacted oral formulations.
Soulairol I; Tarlier N; Bataille B; Cacciaguerra T; Sharkawi T
Int J Pharm; 2015 Mar; 481(1-2):140-7. PubMed ID: 25579869
[TBL] [Abstract][Full Text] [Related]
56. Impact of Hot-Melt Extrusion Processing Conditions on Physicochemical Properties of Amorphous Solid Dispersions Containing Thermally Labile Acrylic Copolymer.
Mathers A; Hassouna F; Malinová L; Merna J; Růžička K; Fulem M
J Pharm Sci; 2020 Feb; 109(2):1008-1019. PubMed ID: 31605688
[TBL] [Abstract][Full Text] [Related]
57. Rheological and solid-state NMR assessments of copovidone/clotrimazole model solid dispersions.
Yang F; Su Y; Zhu L; Brown CD; Rosen LA; Rosenberg KJ
Int J Pharm; 2016 Mar; 500(1-2):20-31. PubMed ID: 26780122
[TBL] [Abstract][Full Text] [Related]
58. Novel Controlled Release Polymer-Lipid Formulations Processed by Hot Melt Extrusion.
Maniruzzaman M; Islam MT; Halsey S; Amin D; Douroumis D
AAPS PharmSciTech; 2016 Feb; 17(1):191-9. PubMed ID: 26689407
[TBL] [Abstract][Full Text] [Related]
59. The manufacture and characterisation of hot-melt extruded enteric tablets.
Andrews GP; Jones DS; Diak OA; McCoy CP; Watts AB; McGinity JW
Eur J Pharm Biopharm; 2008 May; 69(1):264-73. PubMed ID: 18164604
[TBL] [Abstract][Full Text] [Related]
60. Investigation of Thermal and Viscoelastic Properties of Polymers Relevant to Hot Melt Extrusion, IV: Affinisol™ HPMC HME Polymers.
Gupta SS; Solanki N; Serajuddin AT
AAPS PharmSciTech; 2016 Feb; 17(1):148-57. PubMed ID: 26511936
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
